Judo Bio is pioneering oligonucleotide medicines delivered to the kidney, opening the way for new genetic medicines for systemic and renal diseases. With our STRIKE (Selectively Targeting RNA Into KidnEy) platform, we are using a proprietary approach to create ligand-RNA conjugate drugs designed for receptor-mediated update by specific kidney cell types, resulting in gene silencing of disease-modifying target genes. Judo Bio’s initial pipeline programs are megalin-STRIKERs that use the megalin receptor family to selectively deliver siRNA therapeutics to the proximal tubule of the kidney to silence mRNA expression of specific solute carrier proteins (SLCs), thereby inhibiting the uptake of circulating solutes linked to systemic diseases.

Judo Bio

The Cambridge office focuses on advanced research and development in biology, chemistry, and translational science.

Cambridge

Rajiv Patni

This department conducts research and analysis to support organizational goals and drive innovation.

Research Department

This department focuses on innovation and the development of new products and technologies.

Research and Development

This department oversees the strategic direction and governance of the organization through its board members.

Board Governance

This department focuses on the advancement and optimization of chemical processes and compounds for research and development.

Chemistry Development

This department focuses on the research and development of new pharmaceutical therapies and the advancement of drug candidates from discovery through clinical trials.

Drug Development

This department oversees the overall strategic direction and management of the organization.

Judo Bio

Org chart

Teams

Research Department

Research and Development

Board Governance

Chemistry Development

Drug Development

Executive Leadership

Offices

Judo Bio

Org chart

Teams

Research Department

Research and Development

Board Governance

Chemistry Development

Drug Development

Executive Leadership

Offices

Related companies